Analyst Ratings for Agomab Therapeutics (AGMB)
AGMB Rating Summary
AGMB Price Target Summary
- Highest: $36.00 (Leerink)
- Lowest: $28.00 (Morgan Stanley)
- Average: $33.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$33.00 (+133.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2026 | B.Riley | William Wood | New Coverage | Buy (N/A) |
34.00 (N/A) |
11.60 (14.11) |
21.64% | Details |
| 6/22/2026 | H.C. Wainwright | Patrick Trucchio | New Coverage | Buy (N/A) |
35.00 (N/A) |
10.98 (14.11) |
28.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
